Answers are grounded in this paper and cite their sources.
• The recent improvements in liquid biopsy methods for early cancer diagnosis. • Demonstrate the value of liquid biopsy by highlighting how personalized biomarker profiles provide therapeutic alternatives. • Liquid biopsy is crucial for real-time disease monitoring and therapy response. • Liquid biopsy and MRD detection to inform treatment options.
No takes yet. Share an insight, caveat, or question.
Jothi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: